Delivery Order SPE2DB20D7059-SPE2DB24FPYU5
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $3.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,682.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,206,972 units of Methylergonovine 0.2 mg tablets by October 28, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,991.60 with a firm fixed price for the supply of 4563358199 - Methylergonovine 0.2 mg/mL vials. The contract has an ultimate completion date of January 19, 2024 and was awarded on January 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order valued at $3,589.92 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, was awarded by the Defense Logistics Agency (DLA) and involves the delivery of METHYLERGONOVINE 0.2 MG/ML medication with an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,873.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4560862324 - Methylergonovine 0.2 mg/ml vials, with a performance period ending on May 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of Methylergonovine 0.2 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 21, 2024, with a ceiling value of $1,813.53 and a completion date of February 22, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,846.48 Firm Fixed Price Delivery Order is for the supply of 4,565,116,351 methylergonovine 0.2 mg tablets. The contract has an ultimate completion date of July 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and other federal healthcare programs....
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,735,707 units of the medication Methylergonovine 0.2 mg tablet in packages of 28. The contract has a ceiling value of $1,164.00 and is a Firm Fixed Price (FFP) type contract with a delivery date of September 10, 2024. The award was made on September 9, 2024, and there is no set-aside designation for this contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,540.30 firm fixed price delivery order is for the supply of 4567785899 - METHYLERGONOVINE 0.2 MG TABLET 12S. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, identified as SPE2DB22D3102|SPE2DB24FL2QL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,995.36, is for the delivery of the medication methylergonovine 0.2 mg tablets in 12-count packages. This is a firm fixed-price delivery order contract with an ultimate completion date of August 22, 2024. The contract does not have a...